PHARMACOKINETICS IN DRUG-THERAPY .2. APPLICATIONS OF CLINICAL PHARMACOKINETICS IN ASSESSMENT OF THEOPHYLLINE THERAPY

被引：11

作者：

FLOYD, RA ^{[1
]}

COHEN, JL ^{[1
]}

机构：

[1] UNIV SO CALIF,SCH PHARM,CLIN PHARMACOKINET LAB,LOS ANGELES,CA 90033

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1977年 / 34卷 / 04期

关键词：

D O I：

10.1093/ajhp/34.4.402

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：402 / 407

页数：6

共 27 条

[1]

CORNISH HH, 1957, J BIOL CHEM, V228, P315

[2]

ELLIS EF, 1975, NEW DIRECTIONS ASTHM, P317

[3]

FLOYD R, 1976, American Review of Respiratory Disease, V113, P122

[4]

HUNT SN, 1976, CLIN PHARMACOL THER, V19, P546

[5] CLINICAL EXPERIENCE WITH THEOPHYLLINE - RELATIONSHIPS BETWEEN DOSAGE, SERUM CONCENTRATION, AND TOXICITY [J].

JACOBS, MH ;

SENIOR, RM ;

KESSLER, G .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (18) :1983-1986

[6] DECREASED THEOPHYLLINE HALF-LIFE IN CIGARETTE SMOKERS [J].

JENNE, J ;

NAGASAWA, H ;

MCHUGH, R ;

MACDONALD, F ;

WYSE, E .

LIFE SCIENCES, 1975, 17 (02) :195-198

[7]

JENNE JW, 1974, J ALLERGY CLIN IMMUN, V53, P80

[8]

JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349

[9]

JENNE JW, 1976, CLIN PHARMACOL THER, V19, P375

[10]

JENNE JW, 1975, NEW DIRECTIONS ASTHM, P391

← 1 2 3 →